DJIA 18,285.74 0.34 0.00%
NASDAQ 5,090.79 19.05 0.38%
S&P 500 2,130.82 4.97 0.23%
market minute promo

Exelixis (NASDAQ: EXEL)

3.14 -0.04 (-1.26%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

EXEL $3.14 -1.26%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.19
Previous Close $3.18
Daily Range $3.08 - $3.24
52-Week Range $1.26 - $4.55
Market Cap $615.5M
P/E Ratio -2.72
Dividend (Yield) $0.00 (0.0%)
Volume 2,067,773
Average Daily Volume 3,939,338
Current FY EPS -$0.78




Drug Makers

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website:

News & Commentary Rss Feed

You'll Never Guess Why Exelixis, Inc. Romped 14% Higher

Exelixis soars 14% after the company reports better-than-expected first-quarter results, but is something else in its report responsible for today's monstrous gains?

Stifel Talks 5 Biotech Stocks

Exelixis (EXEL) Worth Watching: Stock Moves 10.3% Higher - Tale of the Tape

Exelixis (EXEL) Stock Spikes on First Quarter Earnings Report

Waiting for Exelixis, Inc.'s Meteor to Land

Data from the biotech's kidney cancer trial won't be available until late in the second quarter or potentially even later.

Exelixis' (EXEL) CEO Mike Morrissey on Q1 2015 Results - Earnings Call Transcript

Will Endocyte (ECYT) Disappoint This Earnings Season? - Analyst Blog

Is Exelixis (EXEL) Likely to Report Narrower Loss in Q1? - Analyst Blog

Will Vertex (VRTX) Surprise with a Lower Loss in Q1? - Analyst Blog

Will AmerisourceBergen (ABC) Beat on Earnings Yet Again? - Analyst Blog

See More EXEL News...

EXEL's Top Competitors

EXEL $3.14 (-1.26%)
Current stock: EXEL
TMO $132.84 (0.62%)
Current stock: TMO
ILMN $203.12 (0.57%)
Current stock: ILMN
WAT $133.84 (-0.68%)
Current stock: WAT